Section 1: Foundation Issues 1
Complete Test Bank _
Pharmacotherapy: A Pathophysiologic Approach 10th Edition,
By Joseph Dipiro & 5 More
All Chapters 1-144| 18 Units| Latest Version With Verified And Detailed Answers
, Section 1: Foundation Issues 2
Section 1: Foundation Issues ___________________________________________ 8
Chapter 1: Health Literacy And Medication Use _________________________________ 8
Chapter 2: Cultural Competency ____________________________________________ 18
Chapter 3: Medication Safety Principles And Practices __________________________ 26
Chapter 4: Clinical Pharmacokinetics And Pharmacodynamics ___________________ 34
Chapter 5: Pharmacogenetics_______________________________________________ 41
Chapter 6: Pediatrics ______________________________________________________ 49
Chapter 7: Geriatrics ______________________________________________________ 58
Chapter 8: Palliative Care __________________________________________________ 65
Chapter 9: Clinical Toxicology ______________________________________________ 74
Chapter 10: Clinical Management Of Potential Bioterrorism-Related Conditions _____ 81
Section 2: Cardiovascular Disorders ____________________________________ 88
Chapter 11: Cardiovascular Testing __________________________________________ 88
Chapter 12: Cardiac Arrest _________________________________________________ 90
Chapter 13: Hypertension __________________________________________________ 94
Chapter 14: Chronic Heart Failure __________________________________________ 101
Chapter 15: Acute Decompensated Heart Failure ______________________________ 106
Chapter 16: Stable Ischemic Heart Disease ___________________________________ 111
Chapter 17: Acute Coronary Syndromes _____________________________________ 117
Chapter 18: The Arrhythmias ______________________________________________ 125
Chapter 19: Venous Thromboembolism _____________________________________ 127
Chapter 20: Stroke _______________________________________________________ 132
Chapter 21: Dyslipidemia _________________________________________________ 138
Chapter 22: Peripheral Arterial Disease ______________________________________ 142
Chapter 23: Use Of Vasopressors And Inotropes In The Pharmacotherapy Of Shock 147
Chapter 24: Hypovolemic Shock ___________________________________________ 152
Chapter 25: Introduction To Pulmonary Function Testing _______________________ 157
Section 3: Respiratory Disorders ______________________________________ 161
Chapter 26: Asthma ______________________________________________________ 161
, Section 1: Foundation Issues 3
Chapter 27: Chronic Obstructive Pulmonary Disease __________________________ 165
Chapter 28: Pulmonary Arterial Hypertension ________________________________ 169
Chapter 29: Cystic Fibrosis ________________________________________________ 171
Chapter 30: Drug-Induced Pulmonary Diseases _______________________________ 174
Section 4: Gastrointestinal Disorders __________________________________ 177
Chapter 31: Evaluation Of The Gastrointestinal Tract __________________________ 177
Chapter 32: Gastroesophageal Reflux Disease ________________________________ 181
Chapter 33: Peptic Ulcer Disease And Related Disorders _______________________ 185
Chapter 34: Inflammatory Bowel Disease ____________________________________ 188
Chapter 35: Nausea And Vomiting __________________________________________ 192
Chapter 36: Diarrhea, Constipation, And Irritable Bowel Syndrome _______________ 195
Chapter 37: Portal Hypertension And Cirrhosis _______________________________ 201
Chapter 38: Drug-Induced Liver Disease _____________________________________ 204
Chapter 39: Pancreatitis __________________________________________________ 207
Chapter 40: Viral Hepatitis_________________________________________________ 210
Chapter 41: Celiac Disease ________________________________________________ 215
Section 5: Renal Disorders ___________________________________________ 218
Chapter 42: Evaluation Of Kidney Function __________________________________ 218
Chapter 43: Acute Kidney Injury ____________________________________________ 223
Chapter 44: Chronic Kidney Disease ________________________________________ 228
Chapter 45: Hemodialysis And Peritoneal Dialysis_____________________________ 232
Chapter 46: Drug-Induced Kidney Disease ___________________________________ 236
Chapter 47: Glomerulonephritis ____________________________________________ 240
Chapter 48: Drug Therapy Individualization For Patients With Chronic Kidney Disease
_______________________________________________________________________ 243
Chapter 49: Disorders Of Sodium And Water Homeostasis _____________________ 248
Chapter 50: Disorders Of Calcium And Phosphorus Homeostasis________________ 252
Chapter 51: Disorders Of Potassium And Magnesium Homeostasis ______________ 256
Chapter 52: Acid–Base Disorders __________________________________________ 260
, Section 1: Foundation Issues 4
Section 6: Neurologic Disorders _______________________________________ 266
Chapter 53: Evaluation Of Neurologic Illness _________________________________ 266
Chapter 54: Alzheimer Disease _____________________________________________ 270
Chapter 55: Multiple Sclerosis _____________________________________________ 274
Chapter 56: Epilepsy _____________________________________________________ 278
Chapter 57: Status Epilepticus _____________________________________________ 282
Chapter 58: Acute Management Of The Brain Injury Patient _____________________ 285
Chapter 59: Parkinson Disease_____________________________________________ 289
Chapter 60: Pain Management _____________________________________________ 292
Chapter 61: Headache Disorders ___________________________________________ 296
Section 7: Psychiatric Disorders ______________________________________ 299
Chapter 62: Assessment Of Psychiatric Disorders ____________________________ 299
Chapter 63: Attention Deficit/Hyperactivity Disorder ___________________________ 304
Chapter 64: Eating Disorders ______________________________________________ 308
Chapter 65: Substance-Related Disorders I: Overview And Depressants, Stimulants,
And Hallucinogens _______________________________________________________ 313
Chapter 66: Substance-Related Disorders Ii: Alcohol, Nicotine, And Caffeine ______ 317
Chapter 67: Schizophrenia ________________________________________________ 321
Chapter 68: Major Depressive Disorder ______________________________________ 326
Chapter 69: Bipolar Disorder ______________________________________________ 330
Chapter 70: Anxiety Disorders: Generalized Anxiety, Panic, And Social Anxiety
Disorders_______________________________________________________________ 333
Chapter 71: Posttraumatic Stress Disorder And Obsessive-Compulsive Disorder___ 337
Chapter 72: Sleep–Wake Disorders _________________________________________ 342
Chapter 73: Disorders Associated With Intellectual Disabilities __________________ 345
Section 8: Endocrinologic Disorders ___________________________________ 350
Chapter 74: Diabetes Mellitus ______________________________________________ 350
Chapter 75: Thyroid Disorders _____________________________________________ 355
Chapter 76: Adrenal Gland Disorders _______________________________________ 360
Chapter 77: Pituitary Gland Disorders _______________________________________ 362
, Section 1: Foundation Issues 5
Section 9: Gynecologic And Obstetric Disorders _________________________ 366
Chapter 78: Pregnancy And Lactation: Therapeutic Considerations ______________ 366
Chapter 79: Contraception ________________________________________________ 370
Chapter 80: Menstruation-Related Disorders _________________________________ 375
Chapter 81: Endometriosis ________________________________________________ 379
Chapter 82: Hormone Therapy In Women ____________________________________ 383
Section 10: Urologic Disorders ________________________________________ 387
Chapter 83: Erectile Dysfunction ___________________________________________ 387
Chapter 84: Benign Prostatic Hyperplasia____________________________________ 391
Chapter 85: Urinary Incontinence ___________________________________________ 395
Section 11: Immunologic Disorders ____________________________________ 398
Chapter 86: Function And Evaluation Of The Immune System ___________________ 398
Chapter 87: Systemic Lupus Erythematosus _________________________________ 408
Chapter 88: Drug Allergy __________________________________________________ 412
Chapter 89: Solid-Organ Transplantation ____________________________________ 414
Section 12: Rheumatologic Disorders __________________________________ 418
Chapter 90: Osteoarthritis _________________________________________________ 418
Chapter 91: Rheumatoid Arthritis ___________________________________________ 422
Chapter 92: Osteoporosis And Osteomalacia _________________________________ 427
Chapter 93: Gout And Hyperuricemia _______________________________________ 431
Section 13: Ophthalmic And Otolaryngological Disorders _________________ 432
Chapter 94: Glaucoma ____________________________________________________ 432
Chapter 95: Allergic Rhinitis _______________________________________________ 440
Section 14: Dermatologic Disorders____________________________________ 444
Chapter 96: Acne Vulgaris_________________________________________________ 444
Chapter 97: Psoriasis_____________________________________________________ 447
Chapter 98: Atopic Dermatitis ______________________________________________ 448
Chapter 99: Dermatologic Drug Reactions And Common Skin Conditions _________ 450
, Section 1: Foundation Issues 6
Section 15: Hematologic Disorders ____________________________________ 459
Chapter 100: Anemias ____________________________________________________ 459
Chapter 101: Coagulation Disorders ________________________________________ 470
Chapter 102: Sickle Cell Disease ___________________________________________ 474
Chapter 103: Drug-Induced Hematologic Disorders ____________________________ 478
Section 16: Infectious Diseases _______________________________________ 481
Chapter 104: Laboratory Tests To Direct Antimicrobial Pharmacotherapy _________ 481
Chapter 105: Antimicrobial Regimen Selection _______________________________ 486
Chapter 106: Central Nervous System Infections ______________________________ 495
Chapter 107: Lower Respiratory Tract Infections ______________________________ 499
Chapter 108: Upper Respiratory Tract Infections ______________________________ 507
Chapter 109: Influenza ____________________________________________________ 510
Chapter 110: Skin And Soft-Tissue Infections ________________________________ 515
Chapter 111: Infective Endocarditis _________________________________________ 519
Chapter 112: Tuberculosis ________________________________________________ 524
Chapter 113: Gastrointestinal Infections And Enterotoxigenic Poisonings _________ 529
Chapter 114: Intra-Abdominal Infections _____________________________________ 533
Chapter 115: Parasitic Diseases ____________________________________________ 537
Chapter 116: Urinary Tract Infections And Prostatitis __________________________ 545
Chapter 117: Sexually Transmitted Diseases _________________________________ 549
Chapter 118: Bone And Joint Infections _____________________________________ 565
Chapter 119: Sepsis And Septic Shock ______________________________________ 568
Chapter 120: Superficial Fungal Infections ___________________________________ 572
Chapter 121: Invasive Fungal Infections _____________________________________ 576
Chapter 122: Infections In Immunocompromised Patients ______________________ 581
Chapter 123: Antimicrobial Prophylaxis In Surgery ____________________________ 585
Chapter 124: Travel Health ________________________________________________ 589
Chapter 125: Vaccines And Immunoglobulins ________________________________ 592
Chapter 126: Human Immunodeficiency Virus Infection ________________________ 596
, Section 1: Foundation Issues 7
Section 17: Oncologic Disorders ______________________________________ 600
Chapter 127: Cancer Treatment And Chemotherapy ___________________________ 600
Chapter 128: Breast Cancer _______________________________________________ 604
Chapter 129: Lung Cancer _________________________________________________ 609
Chapter 130: Colorectal Cancer ____________________________________________ 610
Chapter 131: Prostate Cancer ______________________________________________ 614
Chapter 132: Lymphomas _________________________________________________ 615
Chapter 133: Ovarian Cancer ______________________________________________ 617
Chapter 134: Acute Leukemias _____________________________________________ 624
Chapter 135: Chronic Leukemias ___________________________________________ 628
Chapter 136: Multiple Myeloma _____________________________________________ 631
Chapter 137: Myelodysplastic Syndromes ___________________________________ 634
Chapter 138: Renal Cell Carcinoma _________________________________________ 639
Chapter 139: Melanoma ___________________________________________________ 647
Chapter 140: Hematopoietic Stem Cell Transplantation ________________________ 654
Section 18: Nutritional Disorders ______________________________________ 664
Chapter 141: Assessment Of Nutrition Status And Nutrition Requirements ________ 664
Chapter 142: Parenteral Nutrition ___________________________________________ 669
Chapter 143: Enteral Nutrition _____________________________________________ 677
Chapter 144: Obesity _____________________________________________________ 681
, Section 1: Foundation Issues 8
Section 1: Foundation Issues
Chapter 1: Health Literacy And Medication Use
Joseph Dipiro: Pharmacotherapy: A Pathophysiologic Approach 10th Edition| Tenth
Edition
Multiple Choice
1. What Time Will The Trough Blood Level Need To Be Drawn If The Nurse
Administers The Intravenous Medication Dose At 9:00 Am?
A. 6:30 Am
B. 8:30 Am
C. 9:30 Am
D. 11:30 Am
Correct Ans>>B
Trough Blood Levels Measure The Lowest Blood Level Of Medicine And Are
Obtained Just Before The Dose Is Administered. In This Case, 6:30 Am Is Too
Early To Obtain The Blood Level. The Other Two Times Occur After The
Medication Is Administered.
A. 6:30 Am Is Too Early As It Is Well Before The Scheduled Dose.
C. 9:30 Am And D. 11:30 Am Are Both After The Dose Has Been Administered,
So They Are Not Appropriate Times For The Trough Blood Level.
2. What Will The Nurse Expect The Health Care Providers Order To Be When
Starting An Older Adult Patient On Thyroid Hormone Replacement Therapy?
A. Administering A Loading Dose Of The Drug
B. Directions On How To Taper The Drug
C. A Dosage That Is One Third To One Half Of The Regular Dosage
, Section 1: Foundation Issues 9
D. A Dosage That Is Double The Regular Dosage
Correct Ans>>C
To Prevent Toxicity, Dosages For New Medications In Older Adults Should Be
One Third To One Half The Amount Of A Standard Adult Dosage. Loading Doses
Of Drugs Could Cause Severe Toxicity. Tapering Off Is Characteristic Of
Discontinuation Of Medications And Is Not Appropriate For This Situation. Older
Adults Generally Need A Lower Medication Dosage Than Younger Patients.
A. Administering A Loading Dose Could Cause Toxicity, Which Is Not
Recommended For Older Adults.
B. Directions On How To Taper The Drug Are Used For Discontinuation Of
Medication, Not For Initiation.
D. A Dosage That Is Double The Regular Dosage Would Be Dangerous,
Especially For Older Adults Who Have A Slower Metabolism.
Dif: Cognitive Level: Application Ref: P. 29 Obj: 3 Top: Nursing Process Step:
Implementation
Msc: Nclex Client Needs Category: Physiological Integrity
3. Which Drugs Cause Birth Defects?
A. Teratogens
B. Carcinogens
C. Metabolites
D. Placebos Correct Ans>>A
Teratogens Are Drugs That Cause Birth Defects. Carcinogens Cause Cancer.
Metabolites Are The End Product Of Metabolism. Placebos Are Drugs That Have
No Pharmacologic Activity.
B. Carcinogens Cause Cancer, Not Birth Defects.
C. Metabolites Are The Byproducts Of Metabolism, Not Drugs That Cause Birth
Defects.
, Section 1: Foundation Issues 10
D. Placebos Are Inactive Substances That Do Not Have Any Pharmacologic
Effects, Including Birth Defects.
4. Which Life-Threatening Illness May Occur As A Result Of Aspirin (Salicylate)
Administration During Viral Illness To Patients Younger Than 20 Years Of Age?
A. Anaphylactic Shock
B. Reyes Syndrome
C. Chickenpox
D. Influenza A
Correct Ans>>B
Children Are Susceptible To Reyes Syndrome If They Ingest Aspirin At The Time
Of Or Shortly After A Viral Infection Of Chickenpox Or Influenza. Anaphylactic
Shock Is Caused By A Hypersensitivity Reaction. Chickenpox Is The Result Of
Being Infected With A Virus. Influenza A Is Caused By A Pathogen.
A. Anaphylactic Shock Is An Allergic Reaction, Not A Consequence Of Aspirin
Use During A Viral Illness.
C. Chickenpox Is Caused By A Viral Infection But Is Not Related To Aspirin
Administration.
D. Influenza A Is Caused By A Virus, Not Directly By Aspirin Use.
5. Which Classification Of Medications Commonly Causes Allergic Reactions In
Children?
A. Antacids
B. Analgesics
C. Antibiotics
D. Anticonvulsants
Correct Ans>>C
Complete Test Bank _
Pharmacotherapy: A Pathophysiologic Approach 10th Edition,
By Joseph Dipiro & 5 More
All Chapters 1-144| 18 Units| Latest Version With Verified And Detailed Answers
, Section 1: Foundation Issues 2
Section 1: Foundation Issues ___________________________________________ 8
Chapter 1: Health Literacy And Medication Use _________________________________ 8
Chapter 2: Cultural Competency ____________________________________________ 18
Chapter 3: Medication Safety Principles And Practices __________________________ 26
Chapter 4: Clinical Pharmacokinetics And Pharmacodynamics ___________________ 34
Chapter 5: Pharmacogenetics_______________________________________________ 41
Chapter 6: Pediatrics ______________________________________________________ 49
Chapter 7: Geriatrics ______________________________________________________ 58
Chapter 8: Palliative Care __________________________________________________ 65
Chapter 9: Clinical Toxicology ______________________________________________ 74
Chapter 10: Clinical Management Of Potential Bioterrorism-Related Conditions _____ 81
Section 2: Cardiovascular Disorders ____________________________________ 88
Chapter 11: Cardiovascular Testing __________________________________________ 88
Chapter 12: Cardiac Arrest _________________________________________________ 90
Chapter 13: Hypertension __________________________________________________ 94
Chapter 14: Chronic Heart Failure __________________________________________ 101
Chapter 15: Acute Decompensated Heart Failure ______________________________ 106
Chapter 16: Stable Ischemic Heart Disease ___________________________________ 111
Chapter 17: Acute Coronary Syndromes _____________________________________ 117
Chapter 18: The Arrhythmias ______________________________________________ 125
Chapter 19: Venous Thromboembolism _____________________________________ 127
Chapter 20: Stroke _______________________________________________________ 132
Chapter 21: Dyslipidemia _________________________________________________ 138
Chapter 22: Peripheral Arterial Disease ______________________________________ 142
Chapter 23: Use Of Vasopressors And Inotropes In The Pharmacotherapy Of Shock 147
Chapter 24: Hypovolemic Shock ___________________________________________ 152
Chapter 25: Introduction To Pulmonary Function Testing _______________________ 157
Section 3: Respiratory Disorders ______________________________________ 161
Chapter 26: Asthma ______________________________________________________ 161
, Section 1: Foundation Issues 3
Chapter 27: Chronic Obstructive Pulmonary Disease __________________________ 165
Chapter 28: Pulmonary Arterial Hypertension ________________________________ 169
Chapter 29: Cystic Fibrosis ________________________________________________ 171
Chapter 30: Drug-Induced Pulmonary Diseases _______________________________ 174
Section 4: Gastrointestinal Disorders __________________________________ 177
Chapter 31: Evaluation Of The Gastrointestinal Tract __________________________ 177
Chapter 32: Gastroesophageal Reflux Disease ________________________________ 181
Chapter 33: Peptic Ulcer Disease And Related Disorders _______________________ 185
Chapter 34: Inflammatory Bowel Disease ____________________________________ 188
Chapter 35: Nausea And Vomiting __________________________________________ 192
Chapter 36: Diarrhea, Constipation, And Irritable Bowel Syndrome _______________ 195
Chapter 37: Portal Hypertension And Cirrhosis _______________________________ 201
Chapter 38: Drug-Induced Liver Disease _____________________________________ 204
Chapter 39: Pancreatitis __________________________________________________ 207
Chapter 40: Viral Hepatitis_________________________________________________ 210
Chapter 41: Celiac Disease ________________________________________________ 215
Section 5: Renal Disorders ___________________________________________ 218
Chapter 42: Evaluation Of Kidney Function __________________________________ 218
Chapter 43: Acute Kidney Injury ____________________________________________ 223
Chapter 44: Chronic Kidney Disease ________________________________________ 228
Chapter 45: Hemodialysis And Peritoneal Dialysis_____________________________ 232
Chapter 46: Drug-Induced Kidney Disease ___________________________________ 236
Chapter 47: Glomerulonephritis ____________________________________________ 240
Chapter 48: Drug Therapy Individualization For Patients With Chronic Kidney Disease
_______________________________________________________________________ 243
Chapter 49: Disorders Of Sodium And Water Homeostasis _____________________ 248
Chapter 50: Disorders Of Calcium And Phosphorus Homeostasis________________ 252
Chapter 51: Disorders Of Potassium And Magnesium Homeostasis ______________ 256
Chapter 52: Acid–Base Disorders __________________________________________ 260
, Section 1: Foundation Issues 4
Section 6: Neurologic Disorders _______________________________________ 266
Chapter 53: Evaluation Of Neurologic Illness _________________________________ 266
Chapter 54: Alzheimer Disease _____________________________________________ 270
Chapter 55: Multiple Sclerosis _____________________________________________ 274
Chapter 56: Epilepsy _____________________________________________________ 278
Chapter 57: Status Epilepticus _____________________________________________ 282
Chapter 58: Acute Management Of The Brain Injury Patient _____________________ 285
Chapter 59: Parkinson Disease_____________________________________________ 289
Chapter 60: Pain Management _____________________________________________ 292
Chapter 61: Headache Disorders ___________________________________________ 296
Section 7: Psychiatric Disorders ______________________________________ 299
Chapter 62: Assessment Of Psychiatric Disorders ____________________________ 299
Chapter 63: Attention Deficit/Hyperactivity Disorder ___________________________ 304
Chapter 64: Eating Disorders ______________________________________________ 308
Chapter 65: Substance-Related Disorders I: Overview And Depressants, Stimulants,
And Hallucinogens _______________________________________________________ 313
Chapter 66: Substance-Related Disorders Ii: Alcohol, Nicotine, And Caffeine ______ 317
Chapter 67: Schizophrenia ________________________________________________ 321
Chapter 68: Major Depressive Disorder ______________________________________ 326
Chapter 69: Bipolar Disorder ______________________________________________ 330
Chapter 70: Anxiety Disorders: Generalized Anxiety, Panic, And Social Anxiety
Disorders_______________________________________________________________ 333
Chapter 71: Posttraumatic Stress Disorder And Obsessive-Compulsive Disorder___ 337
Chapter 72: Sleep–Wake Disorders _________________________________________ 342
Chapter 73: Disorders Associated With Intellectual Disabilities __________________ 345
Section 8: Endocrinologic Disorders ___________________________________ 350
Chapter 74: Diabetes Mellitus ______________________________________________ 350
Chapter 75: Thyroid Disorders _____________________________________________ 355
Chapter 76: Adrenal Gland Disorders _______________________________________ 360
Chapter 77: Pituitary Gland Disorders _______________________________________ 362
, Section 1: Foundation Issues 5
Section 9: Gynecologic And Obstetric Disorders _________________________ 366
Chapter 78: Pregnancy And Lactation: Therapeutic Considerations ______________ 366
Chapter 79: Contraception ________________________________________________ 370
Chapter 80: Menstruation-Related Disorders _________________________________ 375
Chapter 81: Endometriosis ________________________________________________ 379
Chapter 82: Hormone Therapy In Women ____________________________________ 383
Section 10: Urologic Disorders ________________________________________ 387
Chapter 83: Erectile Dysfunction ___________________________________________ 387
Chapter 84: Benign Prostatic Hyperplasia____________________________________ 391
Chapter 85: Urinary Incontinence ___________________________________________ 395
Section 11: Immunologic Disorders ____________________________________ 398
Chapter 86: Function And Evaluation Of The Immune System ___________________ 398
Chapter 87: Systemic Lupus Erythematosus _________________________________ 408
Chapter 88: Drug Allergy __________________________________________________ 412
Chapter 89: Solid-Organ Transplantation ____________________________________ 414
Section 12: Rheumatologic Disorders __________________________________ 418
Chapter 90: Osteoarthritis _________________________________________________ 418
Chapter 91: Rheumatoid Arthritis ___________________________________________ 422
Chapter 92: Osteoporosis And Osteomalacia _________________________________ 427
Chapter 93: Gout And Hyperuricemia _______________________________________ 431
Section 13: Ophthalmic And Otolaryngological Disorders _________________ 432
Chapter 94: Glaucoma ____________________________________________________ 432
Chapter 95: Allergic Rhinitis _______________________________________________ 440
Section 14: Dermatologic Disorders____________________________________ 444
Chapter 96: Acne Vulgaris_________________________________________________ 444
Chapter 97: Psoriasis_____________________________________________________ 447
Chapter 98: Atopic Dermatitis ______________________________________________ 448
Chapter 99: Dermatologic Drug Reactions And Common Skin Conditions _________ 450
, Section 1: Foundation Issues 6
Section 15: Hematologic Disorders ____________________________________ 459
Chapter 100: Anemias ____________________________________________________ 459
Chapter 101: Coagulation Disorders ________________________________________ 470
Chapter 102: Sickle Cell Disease ___________________________________________ 474
Chapter 103: Drug-Induced Hematologic Disorders ____________________________ 478
Section 16: Infectious Diseases _______________________________________ 481
Chapter 104: Laboratory Tests To Direct Antimicrobial Pharmacotherapy _________ 481
Chapter 105: Antimicrobial Regimen Selection _______________________________ 486
Chapter 106: Central Nervous System Infections ______________________________ 495
Chapter 107: Lower Respiratory Tract Infections ______________________________ 499
Chapter 108: Upper Respiratory Tract Infections ______________________________ 507
Chapter 109: Influenza ____________________________________________________ 510
Chapter 110: Skin And Soft-Tissue Infections ________________________________ 515
Chapter 111: Infective Endocarditis _________________________________________ 519
Chapter 112: Tuberculosis ________________________________________________ 524
Chapter 113: Gastrointestinal Infections And Enterotoxigenic Poisonings _________ 529
Chapter 114: Intra-Abdominal Infections _____________________________________ 533
Chapter 115: Parasitic Diseases ____________________________________________ 537
Chapter 116: Urinary Tract Infections And Prostatitis __________________________ 545
Chapter 117: Sexually Transmitted Diseases _________________________________ 549
Chapter 118: Bone And Joint Infections _____________________________________ 565
Chapter 119: Sepsis And Septic Shock ______________________________________ 568
Chapter 120: Superficial Fungal Infections ___________________________________ 572
Chapter 121: Invasive Fungal Infections _____________________________________ 576
Chapter 122: Infections In Immunocompromised Patients ______________________ 581
Chapter 123: Antimicrobial Prophylaxis In Surgery ____________________________ 585
Chapter 124: Travel Health ________________________________________________ 589
Chapter 125: Vaccines And Immunoglobulins ________________________________ 592
Chapter 126: Human Immunodeficiency Virus Infection ________________________ 596
, Section 1: Foundation Issues 7
Section 17: Oncologic Disorders ______________________________________ 600
Chapter 127: Cancer Treatment And Chemotherapy ___________________________ 600
Chapter 128: Breast Cancer _______________________________________________ 604
Chapter 129: Lung Cancer _________________________________________________ 609
Chapter 130: Colorectal Cancer ____________________________________________ 610
Chapter 131: Prostate Cancer ______________________________________________ 614
Chapter 132: Lymphomas _________________________________________________ 615
Chapter 133: Ovarian Cancer ______________________________________________ 617
Chapter 134: Acute Leukemias _____________________________________________ 624
Chapter 135: Chronic Leukemias ___________________________________________ 628
Chapter 136: Multiple Myeloma _____________________________________________ 631
Chapter 137: Myelodysplastic Syndromes ___________________________________ 634
Chapter 138: Renal Cell Carcinoma _________________________________________ 639
Chapter 139: Melanoma ___________________________________________________ 647
Chapter 140: Hematopoietic Stem Cell Transplantation ________________________ 654
Section 18: Nutritional Disorders ______________________________________ 664
Chapter 141: Assessment Of Nutrition Status And Nutrition Requirements ________ 664
Chapter 142: Parenteral Nutrition ___________________________________________ 669
Chapter 143: Enteral Nutrition _____________________________________________ 677
Chapter 144: Obesity _____________________________________________________ 681
, Section 1: Foundation Issues 8
Section 1: Foundation Issues
Chapter 1: Health Literacy And Medication Use
Joseph Dipiro: Pharmacotherapy: A Pathophysiologic Approach 10th Edition| Tenth
Edition
Multiple Choice
1. What Time Will The Trough Blood Level Need To Be Drawn If The Nurse
Administers The Intravenous Medication Dose At 9:00 Am?
A. 6:30 Am
B. 8:30 Am
C. 9:30 Am
D. 11:30 Am
Correct Ans>>B
Trough Blood Levels Measure The Lowest Blood Level Of Medicine And Are
Obtained Just Before The Dose Is Administered. In This Case, 6:30 Am Is Too
Early To Obtain The Blood Level. The Other Two Times Occur After The
Medication Is Administered.
A. 6:30 Am Is Too Early As It Is Well Before The Scheduled Dose.
C. 9:30 Am And D. 11:30 Am Are Both After The Dose Has Been Administered,
So They Are Not Appropriate Times For The Trough Blood Level.
2. What Will The Nurse Expect The Health Care Providers Order To Be When
Starting An Older Adult Patient On Thyroid Hormone Replacement Therapy?
A. Administering A Loading Dose Of The Drug
B. Directions On How To Taper The Drug
C. A Dosage That Is One Third To One Half Of The Regular Dosage
, Section 1: Foundation Issues 9
D. A Dosage That Is Double The Regular Dosage
Correct Ans>>C
To Prevent Toxicity, Dosages For New Medications In Older Adults Should Be
One Third To One Half The Amount Of A Standard Adult Dosage. Loading Doses
Of Drugs Could Cause Severe Toxicity. Tapering Off Is Characteristic Of
Discontinuation Of Medications And Is Not Appropriate For This Situation. Older
Adults Generally Need A Lower Medication Dosage Than Younger Patients.
A. Administering A Loading Dose Could Cause Toxicity, Which Is Not
Recommended For Older Adults.
B. Directions On How To Taper The Drug Are Used For Discontinuation Of
Medication, Not For Initiation.
D. A Dosage That Is Double The Regular Dosage Would Be Dangerous,
Especially For Older Adults Who Have A Slower Metabolism.
Dif: Cognitive Level: Application Ref: P. 29 Obj: 3 Top: Nursing Process Step:
Implementation
Msc: Nclex Client Needs Category: Physiological Integrity
3. Which Drugs Cause Birth Defects?
A. Teratogens
B. Carcinogens
C. Metabolites
D. Placebos Correct Ans>>A
Teratogens Are Drugs That Cause Birth Defects. Carcinogens Cause Cancer.
Metabolites Are The End Product Of Metabolism. Placebos Are Drugs That Have
No Pharmacologic Activity.
B. Carcinogens Cause Cancer, Not Birth Defects.
C. Metabolites Are The Byproducts Of Metabolism, Not Drugs That Cause Birth
Defects.
, Section 1: Foundation Issues 10
D. Placebos Are Inactive Substances That Do Not Have Any Pharmacologic
Effects, Including Birth Defects.
4. Which Life-Threatening Illness May Occur As A Result Of Aspirin (Salicylate)
Administration During Viral Illness To Patients Younger Than 20 Years Of Age?
A. Anaphylactic Shock
B. Reyes Syndrome
C. Chickenpox
D. Influenza A
Correct Ans>>B
Children Are Susceptible To Reyes Syndrome If They Ingest Aspirin At The Time
Of Or Shortly After A Viral Infection Of Chickenpox Or Influenza. Anaphylactic
Shock Is Caused By A Hypersensitivity Reaction. Chickenpox Is The Result Of
Being Infected With A Virus. Influenza A Is Caused By A Pathogen.
A. Anaphylactic Shock Is An Allergic Reaction, Not A Consequence Of Aspirin
Use During A Viral Illness.
C. Chickenpox Is Caused By A Viral Infection But Is Not Related To Aspirin
Administration.
D. Influenza A Is Caused By A Virus, Not Directly By Aspirin Use.
5. Which Classification Of Medications Commonly Causes Allergic Reactions In
Children?
A. Antacids
B. Analgesics
C. Antibiotics
D. Anticonvulsants
Correct Ans>>C
